Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy

Open access

Abstract

Defects in neuronal migration cause brain malformations, which are associated with intellectual disability (ID) and epilepsy. Using exome sequencing, we identified compound heterozygous variants (p.Arg71His and p. Leu729ThrfsTer6) in TMTC3, encoding transmembrane and tetratricopeptide repeat containing 3, in four siblings with nocturnal seizures and ID. Three of the four siblings have periventricular nodular heterotopia (PVNH), a common brain malformation caused by failure of neurons to migrate from the ventricular zone to the cortex. Expression analysis using patient-derived cells confirmed reduced TMTC3 transcript levels and loss of the TMTC3 protein compared to parental and control cells. As TMTC3 function is currently unexplored in the brain, we gathered support for a neurobiological role for TMTC3 by generating flies with post-mitotic neuron-specific knockdown of the highly conserved Drosophila melanogaster TMTC3 ortholog, CG4050/tmtc3. Neuron-specific knockdown of tmtc3 in flies resulted in increased susceptibility to induced seizures. Importantly, this phenotype was rescued by neuron-specific expression of human TMTC3, suggesting a role for TMTC3 in seizure biology. In addition, we observed co-localization of TMTC3 in the rat brain with vesicular GABA transporter (VGAT), a presynaptic marker for inhibitory synapses. TMTC3 is localized at VGAT positive pre-synaptic terminals and boutons in the rat hypothalamus and piriform cortex, suggesting a role for TMTC3 in the regulation of GABAergic inhibitory synapses. TMTC3 did not co-localize with Vglut2, a presynaptic marker for excitatory neurons. Our data identified TMTC3 as a synaptic protein that is involved in PVNH with ID and epilepsy, in addition to its previously described association with cobblestone lissencephaly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddx316

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Compound heterozygous TMTC3 variants in patients with nocturnal seizures with developmental delay. (A) Pedigree and electropherograms of the compound heterozygous TMTC3 variants in patients with nocturnal seizures with intellectual disability. Different colored circles in pedigrees represent different variants. (B) Protein structure and associated domains of TMTC3 with respective variants identified. RefSeq numbers: NM_181783.3 and NP_ 861448.2. Transmembrane regions are shown in blue and the tetratricopeptide repeats (TPR) domains are shown in green. The location of the TMTC3 variants is shown with the black arrows.
Figure 1. Compound heterozygous TMTC3 variants in patients with nocturnal seizures with developmental delay. (A) Pedigree and electropherograms of the compound heterozygous TMTC3 variants in patients with nocturnal seizures with intellectual disability. Different colored circles in pedigrees represent different variants. (B) Protein structure and associated domains of TMTC3 with respective variants identified. RefSeq numbers: NM_181783.3 and NP_ 861448.2. Transmembrane regions are shown in blue and the tetratricopeptide repeats (TPR) domains are shown in green. The location of the TMTC3 variants is shown with the black arrows.CC BY-NC · PubMed Central
Figure 2. EEG and MRI findings. (A,B) Routine scalp EEG recording from subject II-2 at age 26 years: (A) Interictal recording showing diffuse slowing that is most pronounced in the bitemporal regions (maximum left, arrow). (B) Same recording that also displays an epileptic sharp wave in the left temporal region (arrow). Bipolar recording, sensitivity 7 µV/mm, and bandpass filtered between 0.1 Hz and 70 Hz without a notch filter. The extended standard International 10–20 system of electrode placements was used. EEG for subjects II-1, II-3, and II-4 was not possible, due to behavioral issues. (C,D) Cranial MRI studies: Axial T1-weighted (left panels) and axial T2-weighted (right panels) fast spin-echo images of subjects II-1 (C), II-2 (D), II-3 (E) show bilateral periventricular heterotopias around the temporal horns (arrows). Subject II-4 showed no visible abnormalities.
Figure 2. EEG and MRI findings. (A,B) Routine scalp EEG recording from subject II-2 at age 26 years: (A) Interictal recording showing diffuse slowing that is most pronounced in the bitemporal regions (maximum left, arrow). (B) Same recording that also displays an epileptic sharp wave in the left temporal region (arrow). Bipolar recording, sensitivity 7 µV/mm, and bandpass filtered between 0.1 Hz and 70 Hz without a notch filter. The extended standard International 10–20 system of electrode placements was used. EEG for subjects II-1, II-3, and II-4 was not possible, due to behavioral issues. (C,D) Cranial MRI studies: Axial T1-weighted (left panels) and axial T2-weighted (right panels) fast spin-echo images of subjects II-1 (C), II-2 (D), II-3 (E) show bilateral periventricular heterotopias around the temporal horns (arrows). Subject II-4 showed no visible abnormalities.CC BY-NC · PubMed Central
Figure 3. Depleted TMTC3 protein and transcript expression in cells of patients affected by nocturnal seizures with developmental delay. (A) Immunoblotting analysis showing depleted TMTC3 protein expression in fibroblast cells of patients with nocturnal seizures with intellectual disability. The upper blot shows protein expression of TMTC3, relative to TMTC3 wild type (WT), TMTC3 p.Arg71His/+ (parent 1), and TMTC3 p.Leu728fsTer6/+ (parent 2). The lower blot shows the constitutive expression of α-tubulin as a loading control. Error bars represent standard error of the mean. The data are representative of four separate, independent experiments. The Student's t-test was used to determine the significance of the differences. (B) RT-PCR show TMTC3 transcript expression in patients, both parents, and a healthy control. The data are representative of six independent biological replicates. The Student's t-test was used to determine the significance of the differences. A P-value of less than 0.05 was considered significant. Bar graphs indicate means ± standard deviations. ** represents P-value <0.01.
Figure 3. Depleted TMTC3 protein and transcript expression in cells of patients affected by nocturnal seizures with developmental delay. (A) Immunoblotting analysis showing depleted TMTC3 protein expression in fibroblast cells of patients with nocturnal seizures with intellectual disability. The upper blot shows protein expression of TMTC3, relative to TMTC3 wild type (WT), TMTC3 p.Arg71His/+ (parent 1), and TMTC3 p.Leu728fsTer6/+ (parent 2). The lower blot shows the constitutive expression of α-tubulin as a loading control. Error bars represent standard error of the mean. The data are representative of four separate, independent experiments. The Student's t-test was used to determine the significance of the differences. (B) RT-PCR show TMTC3 transcript expression in patients, both parents, and a healthy control. The data are representative of six independent biological replicates. The Student's t-test was used to determine the significance of the differences. A P-value of less than 0.05 was considered significant. Bar graphs indicate means ± standard deviations. ** represents P-value <0.01.CC BY-NC · PubMed Central
Figure 4. Neuron-specific knockdown of Drosophila tmtc3 causes increased susceptibility to mechanically induced seizures. (A) qPCR results showing average tmtc3 expression levels (±SEM) in whole larvae with ubiquitous UAS-tmtc3-IR expression compared to controls. Significant reduction in tmtc3 mRNA (P< 0.05, Students t-test) was observed with IR1 but not IR2. (B) Boxplot showing the proportion of flies that are immobilized in response to vortexing. Genotypes were compared using the Wilcoxon rank test. * - indicates a significant difference with controls (tmtc3-IR1 + dcr2, P = 0.0006; elavGal4 + dcr2, P = 0.02) and rescue genotypes (hTMT3-1, P = 0.04; hTMTC3-2, P = 0.008). # - indicates a significant difference with tmtc3-IR1 + dcr2 (P = 0.004) and hTMTC3-2 (P = 0.02), and a borderline significant difference with elavGal4 + dcr2 (P = 0.06) and hTMT3-1 (P = 0.08). (C) Boxplots showing the righting time of flies that were immobilized in response to vortexing.
Figure 4. Neuron-specific knockdown of Drosophila tmtc3 causes increased susceptibility to mechanically induced seizures. (A) qPCR results showing average tmtc3 expression levels (±SEM) in whole larvae with ubiquitous UAS-tmtc3-IR expression compared to controls. Significant reduction in tmtc3 mRNA (P< 0.05, Students t-test) was observed with IR1 but not IR2. (B) Boxplot showing the proportion of flies that are immobilized in response to vortexing. Genotypes were compared using the Wilcoxon rank test. * - indicates a significant difference with controls (tmtc3-IR1 + dcr2, P = 0.0006; elavGal4 + dcr2, P = 0.02) and rescue genotypes (hTMT3-1, P = 0.04; hTMTC3-2, P = 0.008). # - indicates a significant difference with tmtc3-IR1 + dcr2 (P = 0.004) and hTMTC3-2 (P = 0.02), and a borderline significant difference with elavGal4 + dcr2 (P = 0.06) and hTMT3-1 (P = 0.08). (C) Boxplots showing the righting time of flies that were immobilized in response to vortexing.CC BY-NC · PubMed Central
Figure 5. TMTC3 is expressed in hypothalamus and piriform cortex of rat brain and co-localizes with vesicular GABA transporter (VGAT) but not vesicular glutamate transporter 2 (Vglut2). (A,B) Low magnification images of TMTC3 immunoreactivity in hypothalamus adjacent to the third ventricle (A) and in piriform cortex (layers 1-3 are indicated) (B). Both images show punta surrounding immunonegative cell bodies; examples of which are marked with white arrows (scale bar is 100 μm). (C–E) Confocal images of the rat hypothalamus showing that TMTC3 does not co-localize with Vglut2, a marker of excitatory nerve terminals. (C) shows Vglut2 staining while panel (D) shows TMTC3 expression. (E) is a merged image stack. (F–H) VGAT is co-localized with TMTC3 in a subpopulation of VGAT positive puncta in the hypothalamus, along the third ventricle. (F) shows VGAT immunoreactivity while (G) shows TMTC3 immunoreactivity. (H) Merged image showing that TMTC3 and VGAT are co-localized in puncta surrounding cell bodies. White represents voxels, where TMTC3 and VGAT are colocalized in three dimensions (60X mag, scale bar is 20 μm). In (I), we show merged channels and co-localization of TMTC3/VGAT at 60 X magnification in piriform cortex. (layers 1–3 are indicated).
Figure 5. TMTC3 is expressed in hypothalamus and piriform cortex of rat brain and co-localizes with vesicular GABA transporter (VGAT) but not vesicular glutamate transporter 2 (Vglut2). (A,B) Low magnification images of TMTC3 immunoreactivity in hypothalamus adjacent to the third ventricle (A) and in piriform cortex (layers 1-3 are indicated) (B). Both images show punta surrounding immunonegative cell bodies; examples of which are marked with white arrows (scale bar is 100 μm). (C–E) Confocal images of the rat hypothalamus showing that TMTC3 does not co-localize with Vglut2, a marker of excitatory nerve terminals. (C) shows Vglut2 staining while panel (D) shows TMTC3 expression. (E) is a merged image stack. (F–H) VGAT is co-localized with TMTC3 in a subpopulation of VGAT positive puncta in the hypothalamus, along the third ventricle. (F) shows VGAT immunoreactivity while (G) shows TMTC3 immunoreactivity. (H) Merged image showing that TMTC3 and VGAT are co-localized in puncta surrounding cell bodies. White represents voxels, where TMTC3 and VGAT are colocalized in three dimensions (60X mag, scale bar is 20 μm). In (I), we show merged channels and co-localization of TMTC3/VGAT at 60 X magnification in piriform cortex. (layers 1–3 are indicated).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 43

Metadata

Authors
Farhan, S. M. K., Nixon, K. C. J., Everest, M., Edwards, T. N., Long, S., Segal, D., Knip, M. J., Arts, H. H., Chakrabarti, R., Wang, J., Robinson, J. F., Lee, D., Mirsattari, S. M., Rupar, C. A., Siu, V. M., FORGE Canada Consortium, Poulter, M. O., Hegele, R. A., & Kramer, J. M.
Affiliations
  • Robarts Research Institute (CA)
  • Western University (CA)
  • Radboud University Medical Center (NL)
  • Children’s Health Research Institute (CA)
  • Department of Medical Imaging
Corresponding author
Kramer, Jamie M
Venue
Human Molecular Genetics
Published
2017-08-16
Volume
26
Issue
21
Pages
4278-4289
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2765091165
Cited by
43
References
50
Citations by year
2026: 4 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 3 · 2017: 1
FWCI
4.27
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Scholarship@Western (Western University) (submittedVersion)
Funders
  • University of Ottawa
  • McGill University
  • Genome Canada (OGI-049)
  • Ontario Genomics (OGI-049)
  • Ontario Genomics Institute (OGI-049)
  • Genome British Columbia
  • Canada Research Chairs
  • University of Toronto
  • Canadian Institutes of Health Research (OGI-049)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
Keywords
periventricular nodular heterotopia, intellectual disability, epilepsy, neuronal migration disorders, brain malformations, synaptic proteins, vesicular GABA transporter, Drosophila, seizure susceptibility, cobblestone lissencephaly, compound heterozygosity, hypothalamus, piriform cortex
MeSH terms
Exome Sequencing, Adult, Animals, Brain, Carrier Proteins, Cerebral Cortex, Drosophila melanogaster, Epilepsy, Female, Heterozygote, Humans, Male, Membrane Proteins, Intellectual Disability, Nervous System Malformations, Neurons, Pedigree, Seizures, Synapses, Presynaptic Terminals, Rats, Periventricular Nodular Heterotopia, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy. https://app.cochat.ai/papers/10.1093/hmg/ddx316
The paper
Farhan, S. M. K., Nixon, K. C. J., Everest, M., Edwards, T. N., Long, S., Segal, D., Knip, M. J., Arts, H. H., Chakrabarti, R., Wang, J., Robinson, J. F., Lee, D., Mirsattari, S. M., Rupar, C. A., Siu, V. M., FORGE Canada Consortium, Poulter, M. O., Hegele, R. A., & Kramer, J. M. (2017). Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddx316

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.